ELIXADA Trademark

Trademark Overview


On Wednesday, May 6, 2020, a trademark application was filed for ELIXADA with the United States Patent and Trademark Office. The USPTO has given the ELIXADA trademark a serial number of 88902639. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by CSL Behring L.L.C.. The ELIXADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia in the nature of pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders
elixada

General Information


Serial Number88902639
Word MarkELIXADA
Filing DateWednesday, May 6, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6406637
Registration DateTuesday, July 6, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia in the nature of pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring L.L.C.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406

Party NameCSL Behring L.L.C.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406

Party NameCSL Behring L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406

Trademark Events


Event DateEvent Description
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 15, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 1, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 1, 2021FINAL REFUSAL E-MAILED
Monday, March 1, 2021FINAL REFUSAL WRITTEN
Wednesday, January 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 8, 2020NON-FINAL ACTION E-MAILED
Saturday, August 8, 2020NON-FINAL ACTION WRITTEN
Saturday, August 1, 2020ASSIGNED TO EXAMINER
Monday, May 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2020NEW APPLICATION ENTERED IN TRAM